Viewing Study NCT06282692

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:44 PM

Ignite Modification Date: 2025-12-28 @ 6:16 AM

Study NCT ID: NCT06282692

Status: RECRUITING

Last Update Posted: 2024-02-28

First Post: 2023-06-21

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

Sponsor: Dr. Soetomo General Hospital

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module